Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Publication of GT200500010ApublicationCriticalpatent/GT200500010A/en
Organic Low-Molecular-Weight Compounds And Preparation Thereof
(AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A COMPUESTOS DE LA FORMULA GENERAL I EN LA QUE R1,R2,Q1,N, SON GRUPOS FUNCIONALES DESCRITOS EN EL EXPEDIENTE. ESTOS COMPUESTOS SON AGONISTAS BETA 2 ADRENERGICOS POR LO QUE SON DE UTILIDAD EN UNA AMPLIA VARIEDAD DE PATOLOGIAS TALES COMO AFECCIONES INFLAMATORIAS, ALERGICAS Y RESPIRATORIAS.THE PRESENT INVENTION REFERS TO COMPOUNDS OF GENERAL FORMULA I IN WHICH R1, R2, Q1, N, ARE FUNCTIONAL GROUPS DESCRIBED IN THE RECORD. THESE COMPOUNDS ARE BETA 2 ADRENERGIC AGONISTS SO THEY ARE USEFUL IN A WIDE VARIETY OF SUCH PATHOLOGIES AS INFLAMMATORY, ALLERGIC AND RESPIRATORY AFFECTIONS.
GT200500010A2004-01-222005-01-19
SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES
GT200500010A
(en)
Compounds derived from 5- [3,3,3-trifluoro-2-hydroxy-1-arylpropyl) amino] -1h-quinolin-2-one, process for their preparation, intermediate compounds, pharmaceutical composition comprising said compound ; Pharmaceutical combination, and its uses in the treatment of inflammatory diseases.
SUBSTITUTED DERIVATIVES OF N- (5- (2-PROPILAMINE.1.HYDROXYETHYL) -2-HDROXIFENIL) METHANE SULFONAMIDE, PHARMACEUTICAL COMPOSITIONS CONTAINING IT AND APPLICATIONS.